Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abe, 2002, Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease, J. Neurosci. Res., 3, 447, 10.1002/jnr.10349
Adamec, 1999, DNA strand breaks in Alzheimer's disease, Brain Res., 1-2, 67, 10.1016/S0006-8993(99)02004-1
Ahlskog, 1995, No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease, Mov. Disord., 5, 566, 10.1002/mds.870100507
Ahmed, 2005, Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment, J. Neurochem., 2, 255, 10.1111/j.1471-4159.2004.02864.x
Aksenova, 1999, Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders, Dement. Geriatr. Cogn. Disord., 2, 158, 10.1159/000017098
Ames, 1993, Oxidants, antioxidants, and the degenerative diseases of aging, Proc. Natl. Acad. Sci. U.S.A., 17, 7915, 10.1073/pnas.90.17.7915
Andersen, 2004, Oxidative stress in neurodegeneration: cause or consequence?, Nat. Med., S18, 10.1038/nrn1434
Anderson, 1996, DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay, J. Neurosci., 5, 1710, 10.1523/JNEUROSCI.16-05-01710.1996
Anzai, 1999, Oxidation-dependent changes in the stability and permeability of lipid bilayers, Antioxid. Redox Signal., 3, 339, 10.1089/ars.1999.1.3-339
Arneson, 2007, Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans, Methods Enzymol., 127, 10.1016/S0076-6879(07)33007-3
Artero, 2006, Revised criteria for mild cognitive impairment: validation within a longitudinal population study, Dement. Geriatr. Cogn. Disord., 5–6, 465, 10.1159/000096287
Aybek, 2007, Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey, Clin. Biochem., 3–4, 172, 10.1016/j.clinbiochem.2006.09.005
Balazs, 1994, Evidence of an oxidative challenge in the Alzheimer's brain, Neurochem. Res., 9, 1131, 10.1007/BF00965146
Baldeiras, 2008, Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease, J. Alzheimers Dis., 1, 117, 10.3233/JAD-2008-15110
Barnham, 2004, Neurodegenerative diseases and oxidative stress, Nat. Rev. Drug Discov., 3, 205, 10.1038/nrd1330
Bartsch, 2005, Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for chemoprevention of inflammation-driven malignancies, Mutat. Res., 1–2, 34, 10.1016/j.mrfmmm.2005.04.013
Barzilai, 2007, The contribution of the DNA damage response to neuronal viability, Antioxid. Redox Signal., 2, 211, 10.1089/ars.2007.9.211
Basu, 2004, Isoprostanes: novel bioactive products of lipid peroxidation, Free Radic. Res., 2, 105, 10.1080/10715760310001646895
Beal, 2005, Mitochondria take center stage in aging and neurodegeneration, Ann. Neurol., 4, 495, 10.1002/ana.20624
Becker, 2004, Cell cycle regulation of neuronal apoptosis in development and disease, Prog. Neurobiol., 1, 1, 10.1016/j.pneurobio.2003.12.005
Beckman, 1998, The free radical theory of aging matures, Physiol. Rev., 2, 547, 10.1152/physrev.1998.78.2.547
Bermejo, 2008, Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from mild cognitive impairment, Free Radic. Res., 2, 162, 10.1080/10715760701861373
Berr, 2000, Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Arteriel, J. Am. Geriatr. Soc., 10, 1285, 10.1111/j.1532-5415.2000.tb02603.x
Bohnstedt, 2003, Determination of isoprostanes in urine samples from Alzheimer patients using porous graphitic carbon liquid chromatography-tandem mass spectrometry, J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci., 1, 11, 10.1016/S1570-0232(03)00600-7
Bourdel-Marchasson, 2001, Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients, Age Ageing, 3, 235, 10.1093/ageing/30.3.235
Bregeon, 2005, Hypothetical role of RNA damage avoidance in preventing human disease, Mutat. Res., 1–2, 293, 10.1016/j.mrfmmm.2005.04.002
Breusing, 2008, Regulation of proteasome-mediated protein degradation during oxidative stress and aging, Biol. Chem., 3, 203, 10.1515/BC.2008.029
Brys, 2009, Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment, Neurobiol. Aging, 5, 682, 10.1016/j.neurobiolaging.2007.08.010
Butterfield, 2004, Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain, Brain Res., 1–2, 1, 10.1016/j.brainres.2003.12.012
Butterfield, 2007, Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder, J. Alzheimers Dis., 1, 61, 10.3233/JAD-2007-12107
Butterfield, 2006, Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease, Neurobiol. Dis., 2, 223, 10.1016/j.nbd.2005.11.002
Butterfield, 2006, Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment, Neurosci. Lett., 3, 170, 10.1016/j.neulet.2005.12.017
Butterfield, 2007, Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease, Brain Res., 243, 10.1016/j.brainres.2007.02.084
Calabrese, 2001, Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity, Neurochem. Res., 6, 739, 10.1023/A:1010955807739
Calabrese, 2006, Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease, Antioxid. Redox Signal., 11–12, 1975, 10.1089/ars.2006.8.1975
Calabrese, 2007, Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes, Neurochem Res., 4–5, 757, 10.1007/s11064-006-9203-y
Calingasan, 1999, Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease, J. Neurochem., 2, 751, 10.1046/j.1471-4159.1999.0720751.x
Cappai, 2008, Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity, Neurochem. Res., 3, 526, 10.1007/s11064-007-9469-8
Carini, 2004, Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins, Mass Spectrom. Rev., 4, 281, 10.1002/mas.10076
Casadesus, 2007, Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease, Mol. Neurodegener., 2, 2, 10.1186/1750-1326-2-2
Casado, 2008, Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias, Neurochem. Res., 3, 450, 10.1007/s11064-007-9453-3
Castegna, 2002, Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I. Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1, Free Radic. Biol. Med., 4, 562, 10.1016/S0891-5849(02)00914-0
Castegna, 2002, Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II. Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71, J. Neurochem., 6, 1524, 10.1046/j.1471-4159.2002.01103.x
Castegna, 2003, Proteomic identification of nitrated proteins in Alzheimer's disease brain, J. Neurochem., 6, 1394, 10.1046/j.1471-4159.2003.01786.x
Castellani, 2002, Role of mitochondrial dysfunction in Alzheimer's disease, J. Neurosci. Res., 3, 357, 10.1002/jnr.10389
Ceballos-Picot, 1996, Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type—place of the extracellular glutathione peroxidase, Free Radic. Biol. Med., 4, 579, 10.1016/0891-5849(95)02058-6
Cecarini, 2007, Oxidative inactivation of the proteasome in Alzheimer's disease, Free Radic. Res., 6, 673, 10.1080/10715760701286159
Cecchi, 2002, Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients, Free Radic. Biol. Med., 10, 1372, 10.1016/S0891-5849(02)01049-3
Cenini, 2008, Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease, Free Radic. Biol. Med., 1, 81, 10.1016/j.freeradbiomed.2008.03.015
Cenini, 2008, Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease, J. Cell Mol. Med., 12, 987, 10.1111/j.1582-4934.2008.00163.x
Chakravarti, 2007, Oxidative modification of proteins: age-related changes, Gerontology, 3, 128, 10.1159/000097865
Chance, 1979, Hydroperoxide metabolism in mammalian organs, Physiol. Rev., 3, 527, 10.1152/physrev.1979.59.3.527
Chen, 2007, Effect of aldehydes derived from oxidative deamination and oxidative stress on beta-amyloid aggregation; pathological implications to Alzheimer's disease, J. Neural. Transm., 6, 835, 10.1007/s00702-007-0697-5
Chen, 2008, Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer's disease, J. Neurochem., 1, 197, 10.1111/j.1471-4159.2008.05603.x
Cherubini, 2005, Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study, Neurobiol. Aging, 7, 987, 10.1016/j.neurobiolaging.2004.09.002
Choi, 2002, Identification of oxidized plasma proteins in Alzheimer's disease, Biochem. Biophys. Res. Commun., 5, 1566, 10.1016/S0006-291X(02)00420-5
Choi, 2004, Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases, J. Biol. Chem., 13, 13256, 10.1074/jbc.M314124200
Chung, 2009, Molecular inflammation: underpinnings of aging and age-related diseases, Ageing Res. Rev., 1, 18, 10.1016/j.arr.2008.07.002
Clayton, 1974, The absence of a pyrimidine dimer repair mechanism in mammalian mitochondria, Proc. Natl. Acad. Sci. U.S.A., 7, 2777, 10.1073/pnas.71.7.2777
Colton, 1987, Production of superoxide anions by a CNS macrophage, the microglia, FEBS Lett., 2, 284, 10.1016/0014-5793(87)80305-8
Colurso, 2003, Quantitative assessment of DNA fragmentation and beta-amyloid deposition in insular cortex and midfrontal gyrus from patients with Alzheimer's disease, Life Sci., 14, 1795, 10.1016/S0024-3205(03)00512-5
Conrad, 2000, Oxidized proteins in Alzheimer's plasma, Biochem. Biophys. Res. Commun., 2, 678, 10.1006/bbrc.2000.3356
Cracowski, 2002, Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications, Trends Pharmacol. Sci., 8, 360, 10.1016/S0165-6147(02)02053-9
Cras, 1990, Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease, Am. J. Pathol., 2, 241
Crouch, 2007, The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease, FEBS J., 15, 3775, 10.1111/j.1742-4658.2007.05918.x
Crow, 1995, The role of peroxynitrite in nitric oxide-mediated toxicity, Curr. Top. Microbiol. Immunol., 57
Curtain, 2001, Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits, J. Biol. Chem., 23, 20466, 10.1074/jbc.M100175200
Dalle-Donne, 2006, Biomarkers of oxidative damage in human disease, Clin. Chem., 4, 601, 10.1373/clinchem.2005.061408
Davis, 1997, Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 9, 4526, 10.1073/pnas.94.9.4526
de Leon, 2004, MRI and CSF studies in the early diagnosis of Alzheimer's disease, J. Intern. Med., 3, 205, 10.1111/j.1365-2796.2004.01381.x
de Leon, 2006, Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment, Neurobiol. Aging, 3, 394, 10.1016/j.neurobiolaging.2005.07.003
de Leon, 2007, Longitudinal CSF isoprostane and MRI atrophy in the progression to AD, J. Neurol., 12, 1666, 10.1007/s00415-007-0610-z
Deshpande, 2006, Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons, J. Neurosci., 22, 6011, 10.1523/JNEUROSCI.1189-06.2006
Di Domenico, 2009, Glutathionylation of the Pro-apoptotic Protein p53 in Alzheimer's Disease Brain: Implications for AD Pathogenesis, Neurochem. Res., 4, 727, 10.1007/s11064-009-9924-9
Ding, 2001, Proteasomes and proteasome inhibition in the central nervous system, Free Radic. Biol. Med., 5, 574, 10.1016/S0891-5849(01)00635-9
Ding, 2005, Ribosome dysfunction is an early event in Alzheimer's disease, J. Neurosci., 40, 9171, 10.1523/JNEUROSCI.3040-05.2005
Ding, 2006, Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease, Neurochem. Res., 5, 705, 10.1007/s11064-006-9071-5
Ding, 2007, Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease, Curr. Alzheimer Res., 1, 73, 10.2174/156720507779939788
Dirican, 2007, Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure treated by hemodialysis, Clin. Nephrol., 3, 144, 10.5414/CNP68144
Dizdaroglu, 2002, Free radical-induced damage to DNA: mechanisms and measurement, Free Radic. Biol. Med., 11, 1102, 10.1016/S0891-5849(02)00826-2
Droge, 2002, Free radicals in the physiological control of cell function, Physiol. Rev., 1, 47, 10.1152/physrev.00018.2001
Edwards, 1989, O6-methylguanine-DNA methyltransferase in lymphocytes of the elderly with and without Alzheimer's disease, Mutat. Res., 5–6, 267, 10.1016/0921-8734(89)90028-3
El Khoury, 1996, Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils, Nature, 6593, 716, 10.1038/382716a0
Engelhart, 2002, Dietary intake of antioxidants and risk of Alzheimer disease, JAMA, 24, 3223, 10.1001/jama.287.24.3223
Esterbauer, 1991, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, Free Radic. Biol. Med., 1, 81, 10.1016/0891-5849(91)90192-6
Feillet-Coudray, 1999, Plasma levels of 8-epiPGF2alpha, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease, Free Radic. Biol. Med., 3–4, 463, 10.1016/S0891-5849(99)00096-9
Fernandes, 1999, Influence of apolipoprotein E genotype on blood redox status of Alzheimer's disease patients, Int. J. Mol. Med., 2, 179
Fiala, 1989, Oxidative DNA and RNA damage in the livers of Sprague-Dawley rats treated with the hepatocarcinogen 2-nitropropane, Cancer Res, 20, 5518
Fillenbaum, 2005, Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E, Ann. Pharmacother., 12, 2009, 10.1345/aph.1G280
Fishel, 2007, DNA repair in neurons: so if they don’t divide what's to repair?, Mutat. Res., 1–2, 24, 10.1016/j.mrfmmm.2006.06.007
Forman, 2007, Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis, Neurology, 10, 757, 10.1212/01.wnl.0000256373.39415.b1
Frank, 2003, Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease, Neurobiol. Aging, 4, 521, 10.1016/S0197-4580(03)00002-2
Friguet, 1997, Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein, FEBS Lett., 1, 21, 10.1016/S0014-5793(97)00148-8
Gabbita, 1998, Increased nuclear DNA oxidation in the brain in Alzheimer's disease, J. Neurochem., 5, 2034, 10.1046/j.1471-4159.1998.71052034.x
Gabbita, 1999, Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain, J. Neurochem., 4, 1660, 10.1046/j.1471-4159.1999.0731660.x
Gale, 1996, Cognitive impairment and mortality in a cohort of elderly people, BMJ, 7031, 608, 10.1136/bmj.312.7031.608
Glabe, 2006, Common mechanisms of amyloid oligomer pathogenesis in degenerative disease, Neurobiol. Aging, 4, 570, 10.1016/j.neurobiolaging.2005.04.017
Glaso, 2004, Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease, J. Nutr. Health Aging, 5, 407
Gomez-Ramos, 2003, Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells, J. Neurosci Res., 6, 863, 10.1002/jnr.10525
Gotz, 1993, The thiobarbituric acid assay reflects susceptibility to oxygen induced lipid peroxidation in vitro rather than levels of lipid hydroperoxides in vivo: a methodological approach, Neurochem. Int., 3, 255, 10.1016/0197-0186(93)90053-8
Growdon, 1998, Consensus report of the working group on: “Molecular and biochemical markers of alzheimer's disease”. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group, Neurobiol Aging, 2, 109
Gutteridge, 1982, Free-radical damage to lipids, amino acids, carbohydrates and nucleic acids determined by thiobarbituric acid reactivity, Int. J. Biochem., 7, 649, 10.1016/0020-711X(82)90050-7
Gutteridge, 1990, The measurement and mechanism of lipid peroxidation in biological systems, Trends Biochem. Sci., 4, 129, 10.1016/0968-0004(90)90206-Q
Hajimohammadreza, 1990, Brain membrane fluidity and lipid peroxidation in Alzheimer's disease, Neurosci. Lett., 2–3, 333, 10.1016/0304-3940(90)90226-Y
Halliwell, 1999
Halliwell, 2004, Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?, Br. J. Pharmacol., 2, 231, 10.1038/sj.bjp.0705776
Hayn, 1996, Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease, Life Sci., 7, 537, 10.1016/0024-3205(96)00334-7
Hebert, 2003, Alzheimer disease in the US population: prevalence estimates using the 2000 census, Arch. Neurol., 8, 1119, 10.1001/archneur.60.8.1119
Helmer, 2003, Association between antioxidant nutritional indicators and the incidence of dementia: results from the PAQUID prospective cohort study, Eur. J. Clin. Nutr., 12, 1555, 10.1038/sj.ejcn.1601724
Hensley, 1994, A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 8, 3270, 10.1073/pnas.91.8.3270
Hensley, 1995, Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation, J. Neurochem., 5, 2146, 10.1046/j.1471-4159.1995.65052146.x
Hensley, 1998, Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation, J. Neurosci., 20, 8126, 10.1523/JNEUROSCI.18-20-08126.1998
Honda, 2005, Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron, J. Biol. Chem., 22, 20978, 10.1074/jbc.M500526200
Hou, 2002, Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1–42) peptide of Alzheimer's disease, J. Biol. Chem., 43, 40173, 10.1074/jbc.C200338200
Ichihashi, 2001, Endogenous formation of protein adducts with carcinogenic aldehydes: implications for oxidative stress, J. Biol. Chem., 26, 23903, 10.1074/jbc.M101947200
Ihara, 2000, Relationship between oxidative stress and apoE phenotype in Alzheimer's disease, Acta Neurol. Scand., 6, 346, 10.1034/j.1600-0404.2000.102006346.x
Iida, 2002, Expression of 8-oxoguanine DNA glycosylase is reduced and associated with neurofibrillary tangles in Alzheimer's disease brain, Acta Neuropathol., 1, 20, 10.1007/s004010100418
Irie, 2003, Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins, Proc. Natl. Acad. Sci. U.S.A., 10, 5634, 10.1073/pnas.1131756100
Irizarry, 2007, Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease, Neurodegener. Dis., 6, 403, 10.1159/000107699
Jacobsen, 2004, Deficiency of the Mre11 DNA repair complex in Alzheimer's disease brains, Brain Res. Mol. Brain Res., 1, 1, 10.1016/j.molbrainres.2004.05.023
Jones, 2006, Redefining oxidative stress, Antioxid. Redox Signal., 9–10, 1865, 10.1089/ars.2006.8.1865
Joseph, 2001, Copernicus revisited: amyloid beta in Alzheimer's disease, Neurobiol. Aging, 1, 131, 10.1016/S0197-4580(00)00211-6
Kadiiska, 2005, Biomarkers of Oxidative Stress Study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning, Free Radic. Biol. Med., 6, 711, 10.1016/j.freeradbiomed.2004.10.024
Kadioglu, 2004, Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer's disease, Biomarkers, 2, 203, 10.1080/13547500410001728390
Kawaguchi-Niida, 2006, Crotonaldehyde accumulates in glial cells of Alzheimer's disease brain, Acta Neuropathol., 5, 422, 10.1007/s00401-006-0044-1
Kawamoto, 2005, Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease, Neurobiol. Aging, 6, 857, 10.1016/j.neurobiolaging.2004.08.011
Kedar, 2003, Can we prevent Parkinson's and Alzheimer's disease?, J. Postgrad. Med., 3, 236
Keller, 1998, Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system, Rev. Neurosci., 2, 105
Keller, 1997, 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes, Neuroscience, 3, 685, 10.1016/S0306-4522(97)00065-1
Keller, 2005, Evidence of increased oxidative damage in subjects with mild cognitive impairment, Neurology, 7, 1152, 10.1212/01.WNL.0000156156.13641.BA
Kim, 2004, Increased urinary F(2)-isoprostanes levels in the patients with Alzheimer's disease, Brain Res. Bull., 1, 47, 10.1016/j.brainresbull.2004.04.016
Kinsella, 1987, Alzheimer's disease fibroblasts have normal repair of N-methyl-N′-nitro-N-nitrosoguanidine-induced DNA damage determined by the alkaline elution technique, Biochem. Biophys. Res. Commun., 2, 355, 10.1016/0006-291X(87)90374-3
Klein, 2001, Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?, Trends Neurosci., 4, 219, 10.1016/S0166-2236(00)01749-5
Korolainen, 2006, Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain, Neurobiol. Aging, 1, 42, 10.1016/j.neurobiolaging.2004.11.010
Kosova, 2007, Advanced oxidation protein products, ferrous oxidation in xylenol orange, and malondialdehyde levels in thyroid cancer, Ann. Surg. Oncol., 9, 2616, 10.1245/s10434-007-9425-5
Kozekov, 2003, DNA interchain cross-links formed by acrolein and crotonaldehyde, J. Am. Chem. Soc., 1, 50, 10.1021/ja020778f
Kruman, 2004, Why do neurons enter the cell cycle?, Cell Cycle, 6, 769
Kuhla, 2007, Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation, J. Biol. Chem., 10, 6984, 10.1074/jbc.M609521200
La Rue, 1997, Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment, Am. J. Clin. Nutr., 1, 20, 10.1093/ajcn/65.1.20
Laboissiere, 1995, The essential function of protein-disulfide isomerase is to unscramble non-native disulfide bonds, J. Biol. Chem., 47, 28006, 10.1074/jbc.270.47.28006
Lambert, 1998, Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins, Proc. Natl. Acad. Sci. U.S.A., 11, 6448, 10.1073/pnas.95.11.6448
Lauderback, 2001, The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42, J. Neurochem., 2, 413, 10.1046/j.1471-4159.2001.00451.x
Laurin, 2004, Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study, Am. J. Epidemiol., 10, 959, 10.1093/aje/kwh124
LeDoux, 2007, Mitochondrial DNA repair: a critical player in the response of cells of the CNS to genotoxic insults, Neuroscience, 4, 1249, 10.1016/j.neuroscience.2006.10.002
Lee, 2004, Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease, Ann. N. Y. Acad. Sci., 1, 10.1196/annals.1297.001
Lee, 2007, Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer's disease, Clin. Biochem., 13–14, 936, 10.1016/j.clinbiochem.2006.11.021
Lepage, 1991, Preparative steps necessary for the accurate measurement of malondialdehyde by high-performance liquid chromatography, Anal. Biochem., 2, 277, 10.1016/0003-2697(91)90392-7
Li, 1997, Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients, J. Mol. Neurosci., 2, 75, 10.1007/BF02736774
Li, 2004, Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice, J. Neurochem., 5, 1308, 10.1111/j.1471-4159.2004.02455.x
Linnane, 1989, Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases, Lancet, 8639, 642, 10.1016/S0140-6736(89)92145-4
Liu, 2005, Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue, Anal. Chem., 18, 5982, 10.1021/ac050624t
Liu, 2006, Detection and quantification of endogenous cyclic DNA adducts derived from trans-4-hydroxy-2-nonenal in human brain tissue by isotope dilution capillary liquid chromatography nanoelectrospray tandem mass spectrometry, Chem. Res. Toxicol., 5, 710, 10.1021/tx0502903
Loidl-Stahlhofen, 1994, Generation of alpha-hydroxyaldehydic compounds in the course of lipid peroxidation, Biochim. Biophys. Acta, 2, 140, 10.1016/0005-2760(94)90020-5
Long, 2008, Neuronal mitochondrial toxicity of malondialdehyde: inhibitory effects on respiratory function and enzyme activities in rat brain mitochondria, Neurochem. Res., 4, 786
LoPachin, 2008, Molecular mechanisms of the conjugated alpha,beta-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases, Toxicol. Sci., 2, 235, 10.1093/toxsci/kfm301
Lovell, 2001, Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid, Arch. Neurol., 3, 392, 10.1001/archneur.58.3.392
Lovell, 2007, Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease, Nucleic Acids Res., 22, 7497, 10.1093/nar/gkm821
Lovell, 2008, Oxidatively modified RNA in mild cognitive impairment, Neurobiol. Dis., 2, 169, 10.1016/j.nbd.2007.07.030
Lovell, 1995, Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease, Neurology, 8, 1594, 10.1212/WNL.45.8.1594
Lovell, 1997, Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease, Neurobiol. Aging, 5, 457, 10.1016/S0197-4580(97)00108-5
Lovell, 1998, Copper, iron and zinc in Alzheimer's disease senile plaques, J. Neurol. Sci., 1, 47, 10.1016/S0022-510X(98)00092-6
Lovell, 1999, Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF, J. Neurochem., 2, 771, 10.1046/j.1471-4159.1999.0720771.x
Lovell, 2000, Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures, Free Radic. Biol. Med., 8, 714, 10.1016/S0891-5849(00)00346-4
Lovell, 2000, Decreased base excision repair and increased helicase activity in Alzheimer's disease brain, Brain Res., 1, 116, 10.1016/S0006-8993(99)02335-5
Lovell, 2001, Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures, Neurobiol. Aging, 2, 187, 10.1016/S0197-4580(00)00235-9
Lu, 2004, Gene regulation and DNA damage in the ageing human brain, Nature, 6994, 883, 10.1038/nature02661
Lucassen, 1997, DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology, J. Neuropathol. Exp. Neurol., 8, 887, 10.1097/00005072-199708000-00007
Luchsinger, 2003, Antioxidant vitamin intake and risk of Alzheimer disease, Arch. Neurol., 2, 203, 10.1001/archneur.60.2.203
Luczaj, 2003, DNA damage caused by lipid peroxidation products, Cell Mol. Biol. Lett., 2, 391
Luth, 2002, Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation, Brain Res., 1–2, 135, 10.1016/S0006-8993(02)03280-8
Lyras, 1997, An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease, J. Neurochem., 5, 2061, 10.1046/j.1471-4159.1997.68052061.x
Malinski, 2007, Nitric oxide and nitroxidative stress in Alzheimer's disease, J. Alzheimers Dis., 2, 207, 10.3233/JAD-2007-11208
Marcus, 1998, Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease, Exp. Neurol., 1, 40, 10.1006/exnr.1997.6750
Mariani, 2005, Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview, J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci., 1, 65, 10.1016/j.jchromb.2005.04.023
Mariani, 2007, Mild cognitive impairment: a systematic review, J. Alzheimers Dis., 1, 23, 10.3233/JAD-2007-12104
Mark, 1995, Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death, J. Neurosci., 9, 6239, 10.1523/JNEUROSCI.15-09-06239.1995
Markesbery, 1999, Oxidative alterations in Alzheimer's disease, Brain Pathol., 1, 133, 10.1111/j.1750-3639.1999.tb00215.x
Markesbery, 1998, Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease, Neurobiol. Aging, 1, 33, 10.1016/S0197-4580(98)00009-8
Markesbery, 2007, Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment, Arch. Neurol., 7, 954, 10.1001/archneur.64.7.954
Markesbery, 2005, Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment, Ann. Neurol., 5, 730, 10.1002/ana.20629
Marques, 2003, Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway, J. Biol. Chem., 30, 28294, 10.1074/jbc.M212265200
Martin, 1990, Chemical influences on the specificity of tyrosine phosphorylation, J. Biol. Chem., 13, 7108, 10.1016/S0021-9258(19)39084-2
Martin-Aragon, 2009, Metalloproteinase's activity and oxidative stress in mild cognitive impairment and Alzheimer's disease, Neurochem. Res., 2, 373, 10.1007/s11064-008-9789-3
Martin-Gallan, 2003, Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications, Free Radic. Biol. Med., 12, 1563, 10.1016/S0891-5849(03)00185-0
Mattson, 1998, Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity, Trends Neurosci., 2, 53, 10.1016/S0166-2236(97)01188-0
Mattson, 2004, Pathways towards and away from Alzheimer's disease, Nature, 7000, 631, 10.1038/nature02621
Maxwell, 2005, Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia, Dement. Geriatr. Cogn. Disord., 1, 45, 10.1159/000085074
Mazur-Kolecka, 2002, Oxidative protein damage in cells engaged in beta-amyloidosis is related to apoE genotype, Neuroreport, 4, 465, 10.1097/00001756-200203250-00021
McGeer, 2000, Alzheimer disease and neuroinflammation, J. Neural. Transm. Suppl., 53
McGrath, 2001, Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde, QJM, 9, 485, 10.1093/qjmed/94.9.485
McIntosh, 1997, Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes, Free Radic. Biol. Med., 2, 183, 10.1016/S0891-5849(96)00573-4
Mecocci, 1993, Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain, Ann. Neurol., 4, 609, 10.1002/ana.410340416
Mecocci, 1994, Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease, Ann. Neurol., 5, 747, 10.1002/ana.410360510
Mecocci, 1998, Oxidative damage to DNA in lymphocytes from AD patients, Neurology, 4, 1014, 10.1212/WNL.51.4.1014
Mecocci, 2000, Plasma antioxidants and longevity: a study on healthy centenarians, Free Radic. Biol. Med., 8, 1243, 10.1016/S0891-5849(00)00246-X
Mecocci, 2002, Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease, Arch. Neurol., 5, 794, 10.1001/archneur.59.5.794
Melov, 2004, Modeling mitochondrial function in aging neurons, Trends Neurosci., 10, 601, 10.1016/j.tins.2004.08.004
Mieyal, 2008, Molecular mechanisms and clinical implications of reversible protein S-glutathionylation, Antioxid. Redox Signal., 11, 1941, 10.1089/ars.2008.2089
Migliore, 2005, Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases, Neurobiol. Aging, 5, 587, 10.1016/j.neurobiolaging.2004.10.002
Migliore, 2005, Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients, Neurobiol. Aging, 5, 567, 10.1016/j.neurobiolaging.2004.07.016
Miyata, 1996, Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides, Nat. Genet., 1, 55, 10.1038/ng0996-55
Montine, 1997, Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4, Am. J. Pathol., 2, 437
Montine, 1998, Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease, Ann. Neurol., 3, 410, 10.1002/ana.410440322
Montine, 1999, Increased CSF F2-isoprostane concentration in probable AD, Neurology, 3, 562, 10.1212/WNL.52.3.562
Montine, 1999, The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients, Am. J. Pathol., 3, 863, 10.1016/S0002-9440(10)65185-1
Montine, 1999, Elevated CSF prostaglandin E2 levels in patients with probable AD, Neurology, 7, 1495, 10.1212/WNL.53.7.1495
Montine, 2000, No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls, Ann. Neurol., 6, 950, 10.1002/1531-8249(200012)48:6<950::AID-ANA23>3.0.CO;2-F
Montine, 2001, Cerebrospinal fluid abeta42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls, Arch. Pathol. Lab. Med., 4, 510, 10.5858/2001-125-0510-CFATAF
Montine, 2002, Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease, Ann. Neurol., 2, 175, 10.1002/ana.10272
Montine, 2007, F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease, J. Mol. Neurosci., 1, 114, 10.1007/s12031-007-0044-1
Montuschi, 2004, Isoprostanes: markers and mediators of oxidative stress, FASEB J., 15, 1791, 10.1096/fj.04-2330rev
Moore, 1991, Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6), J. Neurochem., 2, 518, 10.1111/j.1471-4159.1991.tb08180.x
Moreira, 2008, Nucleic acid oxidation in Alzheimer disease, Free Radic. Biol. Med., 8, 1493, 10.1016/j.freeradbiomed.2008.01.002
Morocz, 2002, Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer's disease, Neurobiol. Aging, 1, 47
Morris, 1998, Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease, Alzheimer. Dis. Assoc. Disord., 3, 121, 10.1097/00002093-199809000-00001
Morris, 2002, Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study, JAMA, 24, 3230, 10.1001/jama.287.24.3230
Morrow, 2005, Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans, Arterioscler. Thromb. Vasc. Biol., 2, 279, 10.1161/01.ATV.0000152605.64964.c0
Morrow, 1992, Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids, Proc. Natl. Acad. Sci. U.S.A., 22, 10721, 10.1073/pnas.89.22.10721
Morrow, 1995, Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage, N. Engl. J. Med., 18, 1198, 10.1056/NEJM199505043321804
Mullaart, 1990, Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients, Neurobiol. Aging, 3, 169, 10.1016/0197-4580(90)90542-8
Nakamura, 2005, Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy, J. Card. Fail., 2, 117, 10.1016/j.cardfail.2004.05.005
Nath, 1998, 1,N2-propanodeoxyguanosine adducts: potential new biomarkers of smoking-induced DNA damage in human oral tissue, Cancer Res., 4, 581
Nayak, 2007, Protein thiols and thiobarbituric acid reactive substance status in colon cancer patients, Scand. J. Gastroenterol., 7, 848, 10.1080/00365520601137264
Newman, 2007, An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach, J. Neurosci. Res., 7, 1506, 10.1002/jnr.21275
Niki, 1993, Dynamics of lipid peroxidation and its inhibition by antioxidants, Biochem. Soc. Trans., 2, 313, 10.1042/bst0210313
Nourooz-Zadeh, 1999, F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease, J. Neurochem., 2, 734, 10.1046/j.1471-4159.1999.0720734.x
Nunomura, 1999, RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease, J. Neurosci., 6, 1959, 10.1523/JNEUROSCI.19-06-01959.1999
Nunomura, 2001, Oxidative damage is the earliest event in Alzheimer disease, J. Neuropathol. Exp. Neurol., 8, 759, 10.1093/jnen/60.8.759
Nunomura, 2004, Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease, Neurobiol. Dis., 1, 108, 10.1016/j.nbd.2004.06.003
Nunomura, 2006, Oxidative damage to RNA in neurodegenerative diseases, J. Biomed. Biotechnol., 3, 82323
Nunomura, 2006, Involvement of oxidative stress in the early-stage of Alzheimer's disease: implications for therapeutics, Trends Alzheimer's Dis. Res.
Ozcankaya, 2002, Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study, Croat. Med. J., 1, 28
Palmer, 1994, Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease, Brain Res., 1–2, 338, 10.1016/0006-8993(94)91670-5
Pamplona, 2005, Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets, J. Biol. Chem., 22, 21522, 10.1074/jbc.M502255200
Pappolla, 1992, Immunohistochemical evidence of oxidative stress in Alzheimer's disease, Am. J. Pathol., 3, 621
Parshad, 1996, Fluorescent light-induced chromatid breaks distinguish Alzheimer disease cells from normal cells in tissue culture, Proc. Natl. Acad. Sci. U.S.A., 10, 5146, 10.1073/pnas.93.10.5146
Pedersen, 1999, The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells, Exp. Neurol., 1, 1, 10.1006/exnr.1998.6890
Perrig, 1997, The relation between antioxidants and memory performance in the old and very old, J. Am. Geriatr. Soc., 6, 718, 10.1111/j.1532-5415.1997.tb01476.x
Petersen, 2005, Vitamin E and donepezil for the treatment of mild cognitive impairment, N. Engl. J. Med., 23, 2379, 10.1056/NEJMoa050151
Picklo, 2007, Mitochondrial effects of lipid-derived neurotoxins, J. Alzheimers Dis., 2, 185, 10.3233/JAD-2007-12209
Pincemail, 1996, Oxidative stress in clinical situations—fact or fiction?, Eur. J. Anaesthesiol., 3, 219, 10.1097/00003643-199605000-00002
Polidori, 2002, Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease, J. Alzheimers Dis., 6, 517, 10.3233/JAD-2002-4608
Polidori, 2001, Peripheral non-enzymatic antioxidant changes with human aging: a selective status report, Biogerontology, 2, 99, 10.1023/A:1011593319127
Polidori, 2001, Profiles of antioxidants in human plasma, Free Radic. Biol. Med., 5, 456, 10.1016/S0891-5849(00)00345-2
Polidori, 2004, Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia, Dement. Geriatr. Cogn. Disord., 3–4, 265, 10.1159/000080027
Polidori, 2007, Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease, Amino Acids, 4, 553, 10.1007/s00726-006-0431-x
Porter, 1995, Mechanisms of free radical oxidation of unsaturated lipids, Lipids, 4, 277, 10.1007/BF02536034
Praticò, 2008, Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows, Ann. N. Y. Acad. Sci., 70, 10.1196/annals.1427.010
Praticò, 2004, Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease, J. Alzheimers Dis., 2, 171, 10.3233/JAD-2004-6209
Praticò, 1998, Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo, FASEB J., 15, 1777, 10.1096/fasebj.12.15.1777
Praticò, 2000, Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity, Ann. Neurol., 5, 809, 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9
Praticò, 2001, Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis, J. Neurosci., 12, 4183, 10.1523/JNEUROSCI.21-12-04183.2001
Praticò, 2002, Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease, Arch. Neurol., 6, 972, 10.1001/archneur.59.6.972
Pryor, 1990, Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids, Free Radic. Biol. Med., 6, 541, 10.1016/0891-5849(90)90153-A
Quinn, 2004, Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease, J. Alzheimers Dis., 1, 93, 10.3233/JAD-2004-6110
Ramassamy, 2000, Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain, Neurobiol. Dis., 1, 23, 10.1006/nbdi.1999.0273
Reddy, 2008, Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease, Trends Mol. Med., 2, 45, 10.1016/j.molmed.2007.12.002
Reddy, 2002, Identification of glutathione modifications by cigarette smoke, Free Radic. Biol. Med., 11, 1490, 10.1016/S0891-5849(02)01079-1
Reed, 2008, Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease, Neurobiol. Dis., 1, 107, 10.1016/j.nbd.2007.12.007
Reich, 2001, Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease, Am. J. Pathol., 1, 293, 10.1016/S0002-9440(10)63968-5
Repetto, 1999, Peripheral markers of oxidative stress in probable Alzheimer patients, Eur. J. Clin. Invest., 7, 643, 10.1046/j.1365-2362.1999.00506.x
Rinaldi, 2003, Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease, Neurobiol. Aging, 7, 915, 10.1016/S0197-4580(03)00031-9
Riviere, 1998, Low plasma vitamin C in Alzheimer patients despite an adequate diet, Int. J. Geriatr. Psychiatry, 11, 749, 10.1002/(SICI)1099-1166(1998110)13:11<749::AID-GPS860>3.0.CO;2-T
Roberts, 1997, The generation and actions of isoprostanes, Biochim. Biophys. Acta, 2, 121, 10.1016/S0005-2760(96)00162-2
Roberts, 2002, Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation, Cell. Mol. Life Sci., 5, 808, 10.1007/s00018-002-8469-8
Roberts, 1998, Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid, J. Biol. Chem., 22, 13605, 10.1074/jbc.273.22.13605
Rottkamp, 2002, The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease, Peptides, 7, 1333, 10.1016/S0196-9781(02)00069-4
Ryberg, 2004, Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease, Neurochem. Int., 1, 57, 10.1016/j.neuint.2003.12.012
Sano, 1997, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study, N. Engl. J. Med., 17, 1216, 10.1056/NEJM199704243361704
Sathiyapriya, 2007, Enhanced glycation of hemoglobin and plasma proteins is associated with increased lipid peroxide levels in non-diabetic hypertensive subjects, Arch. Med. Res., 8, 822, 10.1016/j.arcmed.2007.05.008
Sayre, 1997, Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal, Chem. Res. Toxicol., 5, 518, 10.1021/tx970009n
Sayre, 1997, 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease, J. Neurochem., 5, 2092, 10.1046/j.1471-4159.1997.68052092.x
Schmidt, 1998, Plasma antioxidants and cognitive performance in middle-aged and older adults: results of the Austrian Stroke Prevention Study, J. Am. Geriatr. Soc., 11, 1407, 10.1111/j.1532-5415.1998.tb06008.x
Schopfer, 2003, NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response?, Trends Biochem. Sci., 12, 646, 10.1016/j.tibs.2003.10.006
Schuessel, 2004, Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer's disease brain, J. Neural. Transm., 9, 1167
Seidl, 1997, Evidence against increased oxidative DNA-damage in Down syndrome, Neurosci. Lett., 3, 137, 10.1016/S0304-3940(97)00748-9
Serra, 2001, Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients, J. Neural. Transm., 10, 1135, 10.1007/s007020170003
Shadel, 2005, Mitochondrial DNA, aconitase ‘wraps’ it up, Trends Biochem. Sci., 6, 294, 10.1016/j.tibs.2005.04.007
Shan, 2006, Quantification of oxidized RNAs in Alzheimer's disease, Neurobiol. Aging, 5, 657, 10.1016/j.neurobiolaging.2005.03.022
Shan, 2003, The identification and characterization of oxidized RNAs in Alzheimer's disease, J. Neurosci., 12, 4913, 10.1523/JNEUROSCI.23-12-04913.2003
Shan, 2007, Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression, FASEB J., 11, 2753, 10.1096/fj.07-8200com
Shao, 2008, Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain, Free Radic. Biol. Med., 6, 813, 10.1016/j.freeradbiomed.2008.06.003
Shringarpure, 2000, 4-Hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: possible importance in Alzheimer's disease, Cell. Mol. Life Sci., 12, 1802, 10.1007/PL00000660
Siegel, 2007, The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation, Biochemistry, 6, 1503, 10.1021/bi061853s
Siems, 2002, Oxidative stress in chronic renal failure as a cardiovascular risk factor, Clin. Nephrol., S12
Sies, 1985
Sinclair, 1998, Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia, Int. J. Geriatr. Psychiatry, 12, 840, 10.1002/(SICI)1099-1166(1998120)13:12<840::AID-GPS877>3.0.CO;2-R
Skinner, 1993, Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects, Brain, 717, 10.1093/brain/116.3.717
Small, 1997, Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society, JAMA, 16, 1363, 10.1001/jama.278.16.1363
Smith, 1991, Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 23, 10540, 10.1073/pnas.88.23.10540
Smith, 1997, Iron accumulation in Alzheimer disease is a source of redox-generated free radicals, Proc. Natl. Acad. Sci. U.S.A., 18, 9866, 10.1073/pnas.94.18.9866
Smith, 1997, Widespread peroxynitrite-mediated damage in Alzheimer's disease, J. Neurosci., 8, 2653, 10.1523/JNEUROSCI.17-08-02653.1997
Sohal, 1993, Protein oxidative damage is associated with life expectancy of houseflies, Proc. Natl. Acad. Sci. U.S.A., 15, 7255, 10.1073/pnas.90.15.7255
Song, 2004, Alzheimer's disease meets the ubiquitin-proteasome system, Trends Mol. Med., 11, 565, 10.1016/j.molmed.2004.09.005
Song, 2008, Neurofurans, novel indices of oxidant stress derived from docosahexaenoic acid, J. Biol. Chem., 1, 6, 10.1074/jbc.M706124200
Stadelmann, 1998, Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis, J. Neuropathol. Exp. Neurol., 5, 456, 10.1097/00005072-199805000-00009
Stadtman, 2003, Free radical-mediated oxidation of free amino acids and amino acid residues in proteins, Amino Acids, 3–4, 207, 10.1007/s00726-003-0011-2
Stadtman, 2003, Oxidation of methionine residues of proteins: biological consequences, Antioxid. Redox Signal., 5, 577, 10.1089/152308603770310239
Stocker, 2004, Role of oxidative modifications in atherosclerosis, Physiol. Rev., 4, 1381, 10.1152/physrev.00047.2003
Su, 1994, Immunohistochemical evidence for apoptosis in Alzheimer's disease, Neuroreport, 18, 2529, 10.1097/00001756-199412000-00031
Su, 1997, Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain, Brain Res., 1–2, 193, 10.1016/S0006-8993(97)81703-9
Subbarao, 1990, Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro, J. Neurochem., 1, 342, 10.1111/j.1471-4159.1990.tb08858.x
Sugaya, 1997, Topographic associations between DNA fragmentation and Alzheimer's disease neuropathology in the hippocampus, Neurochem. Int., 2, 275, 10.1016/S0197-0186(96)00158-1
Sultana, 2006, Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis, Neurobiol. Aging, 7, 918, 10.1016/j.neurobiolaging.2005.05.005
Sultana, 2006, Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD, Neurobiol. Aging, 11, 1564, 10.1016/j.neurobiolaging.2005.09.021
Sultana, 2006, Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1–42), J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci., 1, 3, 10.1016/j.jchromb.2005.09.024
Sultana, 2006, Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics, Antioxid. Redox Signal., 11–12, 2021, 10.1089/ars.2006.8.2021
Sultana, 2006, Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach, Neurobiol. Dis., 1, 76, 10.1016/j.nbd.2005.10.004
Sultana, 2008, Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment, Neurochem. Res., 12, 2540, 10.1007/s11064-008-9593-0
Szymanski, 2005, A new frontier for molecular medicine: noncoding RNAs, Biochim. Biophys. Acta, 1, 65
Tamagno, 2006, The various aggregation states of beta-amyloid 1–42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression, Free Radic. Biol. Med., 2, 202, 10.1016/j.freeradbiomed.2006.01.021
Te Koppele, 1996, 8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease, Neurobiol. Aging, 6, 819, 10.1016/S0197-4580(96)00165-0
Tohgi, 1999, Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease, Neurosci. Lett., 1, 52, 10.1016/S0304-3940(99)00406-1
Tuppo, 2001, Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease, Brain Res. Bull., 5, 565, 10.1016/S0361-9230(01)00450-6
Uchida, 2000, Role of reactive aldehyde in cardiovascular diseases, Free Radic. Biol. Med., 12, 1685, 10.1016/S0891-5849(00)00226-4
Uchida, 2003, Histidine and lysine as targets of oxidative modification, Amino Acids, 3–4, 249, 10.1007/s00726-003-0015-y
Uchida, 2003, 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress, Prog. Lipid Res., 4, 318, 10.1016/S0163-7827(03)00014-6
Uchida, 1998, Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins, J. Biol. Chem., 26, 16058, 10.1074/jbc.273.26.16058
Valko, 2007, Free radicals and antioxidants in normal physiological functions and human disease, Int. J. Biochem. Cell Biol., 1, 44, 10.1016/j.biocel.2006.07.001
Vatassery, 2004, Impairment of brain mitochondrial oxidative phosphorylation accompanying vitamin E oxidation induced by iron or reactive nitrogen species: a selective review, Neurochem. Res., 11, 1951, 10.1007/s11064-004-6870-4
Volkel, 2005, Glutathione conjugates of 4-hydroxy-2(E)-nonenal as biomarkers of hepatic oxidative stress-induced lipid peroxidation in rats, Free Radic. Biol. Med., 11, 1526, 10.1016/j.freeradbiomed.2005.02.015
Volkel, 2006, Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease, Neurochem. Int., 8, 679, 10.1016/j.neuint.2005.12.003
Voss, 2007, The nuclear proteasome and the degradation of oxidatively damaged proteins, Amino Acids, 4, 527, 10.1007/s00726-006-0428-5
Waddington, 1999, Plasma F2-isoprostane levels are increased in Alzheimer's disease: evidence of increased oxidative stress in vivo, Alzheimer's Rep., 2, 277
Wallace, 2005, A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine, Annu. Rev. Genet., 359, 10.1146/annurev.genet.39.110304.095751
Walsh, 2002, Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo, Nature, 6880, 535, 10.1038/416535a
Wamer, 1997, In vitro photooxidation of nucleic acids by ultraviolet A radiation, Photochem. Photobiol., 3, 560
Wang, 2005, Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease, J. Neurochem., 4, 953, 10.1111/j.1471-4159.2005.03053.x
Wang, 2006, Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment, J. Neurochem., 3, 825, 10.1111/j.1471-4159.2005.03615.x
Weissman, 2007, Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment, Nucleic Acids Res., 16, 5545, 10.1093/nar/gkm605
Williams, 2005, Analysis of derivatized biogenic aldehydes by LC tandem mass spectrometry, Anal. Chem., 10, 3383, 10.1021/ac048265+
Williams, 2006, Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease, Neurobiol. Aging, 8, 1094, 10.1016/j.neurobiolaging.2005.06.004
Wilson, 2002, Dietary hydroxy fatty acids are absorbed in humans: implications for the measurement of ‘oxidative stress’ in vivo, Free Radic. Biol. Med., 2, 162, 10.1016/S0891-5849(01)00780-8
Winblad, 2004, Mild cognitive impairment—beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment, J. Intern. Med., 3, 240, 10.1111/j.1365-2796.2004.01380.x
Yan, 1994, Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress, Proc. Natl. Acad. Sci. U.S.A., 16, 7787, 10.1073/pnas.91.16.7787
Yan, 1995, Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide, Nat. Med., 7, 693, 10.1038/nm0795-693
Yan, 1996, RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease, Nature, 6593, 685, 10.1038/382685a0
Yan, 1997, Oxidative damage during aging targets mitochondrial aconitase, Proc. Natl. Acad. Sci. U.S.A., 21, 11168, 10.1073/pnas.94.21.11168
Yao, 2003, Enhanced brain levels of 8,12-iso-iPF2alpha-VI differentiate AD from frontotemporal dementia, Neurology, 4, 475, 10.1212/01.WNL.0000070185.02546.5D
Yehuda, 2002, The role of polyunsaturated fatty acids in restoring the aging neuronal membrane, Neurobiol. Aging, 5, 843, 10.1016/S0197-4580(02)00074-X
Zandi, 2004, Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study, Arch. Neurol., 1, 82, 10.1001/archneur.61.1.82
Zhu, 2000, Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease, J. Neuropathol. Exp. Neurol., 10, 880, 10.1093/jnen/59.10.880
Zhu, 2004, Alzheimer's disease: the two-hit hypothesis, Lancet Neurol., 4, 219, 10.1016/S1474-4422(04)00707-0
Zhu, 2007, Alzheimer disease, the two-hit hypothesis: an update, Biochim. Biophys. Acta, 4, 494, 10.1016/j.bbadis.2006.10.014